|
| |
| | | 67758 | | 01.02.2021 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Kesimpta | Injektionslösung in Fertigpen | Injektionslösung in Fertigpen (Ofatumumabum 20mg / 0.4ml) | L04AG12 | CI | | 02 | Kesimpta | | (Ofatumumabum 20 mg) | L04AG12 | |
|
|
|